How a DNA sequencing start-up proved it is no pushover
TwinStrand co-founder’s grandfather famously didn’t patent the polio vaccine, but Dr Jesse Salk believes that protecting inventions is key to getting products to reach the market
Stay updated with breaking news from Jesse Salk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TwinStrand co-founder’s grandfather famously didn’t patent the polio vaccine, but Dr Jesse Salk believes that protecting inventions is key to getting products to reach the market
Silicon Valley cancer diagnostics trailblazer, Guardant Health, is gearing up for an intense legal tussle as it appeals an adverse $83.4 million verdict handed down a day earlier in a high-stakes patent battle against a Seattle-based rival. Unanimous Blow in Wilmington, Delaware The seismic verdict, delivered in Wilmington, Delaware on Tuesday, concluded a gripping five-day
TwinStrand Biosciences Expands Executive Team With Appointment of Goran Pljevaljcic as Chief Commercial Officer - read this article along with other careers information, tips and advice on BioSpace
The technique, called single-molecule mutation sequencing (SMM-seq), uses rolling circle amplification to increase the number of copies of parental strands used for sequencing.
Called Concatenating Original Duplex for Error Correction (CODEC), the method ligates both strands of a DNA molecule into a single duplex for sequencing.